Početna › Akutna limfoblastna leukemija
Kliničke studije za Akutna limfoblastna leukemija koje traže sudionike u SAD-u
134 studija za Akutna limfoblastna leukemija traži sudionike na lokacijama širom Sjedinjenih Američkih Država.
Gradovi s najviše studija
- Houston, TX28 studija
- New York City, NY24 studija
- Baldwin Park, CA21 studija
- Seattle, WA21 studija
- Atlanta, GA19 studija
- Chicago, IL19 studija
- Philadelphia, PA16 studija
- Memphis, TN16 studija
- Washington, DC16 studija
- Boston, MA15 studija
- Los Angeles, CA14 studija
- Durham, NC13 studija
- Mountain View, CA13 studija
- Cincinnati, OH12 studija
- Minneapolis, MN12 studija
- Columbus, OH11 studija
- Tampa, FL10 studija
- Salt Lake City, UT10 studija
- Baltimore, MD9 studija
- Portland, OR9 studija
- Miami, FL8 studija
- Aurora, CO8 studija
- San Antonio, TX8 studija
- Nashville, TN8 studija
- Edison, NJ8 studija
- Charlotte, NC8 studija
- Cleveland, OH7 studija
- Birmingham, AL7 studija
- Denver, CO7 studija
- Pittsburgh, PA6 studija
- Oklahoma City, OK6 studija
- Milwaukee, WI6 studija
- Detroit, MI6 studija
- St. Louis, MO6 studija
- Phoenix, AZ6 studija
- San Diego, CA6 studija
- Queens, NY6 studija
- San Francisco, CA5 studija
- Clifton, NJ5 studija
- The Bronx, NY5 studija
Po državama
- Alabama7 studija
- Arizona6 studija
- Arkansas5 studija
- Colorado12 studija
- Connecticut3 studija
- Distrikt Columbia10 studija
- Florida19 studija
- Georgia20 studija
- Havaji3 studija
- Illinois20 studija
- Indiana6 studija
- Iowa5 studija
- Kalifornija40 studija
- Kansas5 studija
- Kentucky4 studija
- Louisiana6 studija
- Maine3 studija
- Maryland16 studija
- Massachusetts15 studija
- Michigan8 studija
- Minnesota14 studija
- Mississippi3 studija
- Missouri6 studija
- Nebraska4 studija
- Nevada3 studija
- New Jersey11 studija
- New Mexico3 studija
- New York32 studija
- North Carolina21 studija
- Ohio21 studija
- Oklahoma8 studija
- Oregon10 studija
- Pennsylvania21 studija
- Rhode Island3 studija
- South Carolina5 studija
- South Dakota3 studija
- Tennessee22 studija
- Texas30 studija
- Utah10 studija
- Virginia9 studija
- Washington22 studija
- West Virginia4 studija
- Wisconsin9 studija
Nedavno ažurirane studije
Službeni tekst studije (engleski)
Activated T-Cells Expressing 2nd or 3rd Generation CD19-Specific CAR, Advanced B-Cell NHL, ALL, and CLL (SAGAN)
U tijeku regrutacijaFaza 1
Do 75 godina · Oba spola · Ažurirano 2. lis 2026. · NCT01853631A Multicenter Study to Evaluate Next-Generation Sequencing (NGS) Testing and Monitoring of B-Cell Recovery to Guide Management Following Chimeric Antigen Receptor T-cell (CART) Induced Remission in Children and Young Adults With B Lineage Acute Lymph...
U tijeku regrutacija
Od 1 do 25 godina · Oba spola · Ažurirano 2. lis 2026. · NCT05621291Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic Malignancies
U tijeku regrutacijaFaza 1
Od 18 do 120 godina · Oba spola · Ažurirano 2. lis 2026. · NCT06904066Anti-CRLF2-R/TSLPR Chimeric Antigen Receptor T Cells (TSLPR-CART) in Participants With Recurrent or Refractory CRLF2-R/TSLPR-Overexpressing B-Cell Acute Lymphoblastic Leukemia (B-ALL)
U tijeku regrutacijaFaza 1
Od 18 do 120 godina · Oba spola · Ažurirano 2. lis 2026. · NCT07572136Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
U tijeku regrutacijaOpažajna studijaZdravi dobrovoljci dobrodošli
Od 40 do 75 godina · Oba spola · Ažurirano 2. lis 2026. · NCT05334069Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
U tijeku regrutacijaOpažajna studija
Od 0 do 38 godina · Oba spola · Ažurirano 1. lis 2026. · NCT06131801CD22 CAR T-cells to Extend Remission Following Commercial CD19 CAR T-cells in Children, Adolescents, and Adults With Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia
U tijeku regrutacijaFaza 2
Od 3 do 65 godina · Oba spola · Ažurirano 30. ruj 2026. · NCT07328503CD19/CD22 Bicistronic Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory B Cell Malignancies
U tijeku regrutacijaFaza 1/2
Od 3 do 39 godina · Oba spola · Ažurirano 30. ruj 2026. · NCT05442515A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies
U tijeku regrutacijaFaza 1
Od 12 do 78 godina · Oba spola · Ažurirano 29. ruj 2026. · NCT03802695A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (T-RRex)
U tijeku regrutacijaFaza 2
6 Months · Oba spola · Ažurirano 28. ruj 2026. · NCT06514794Study of KTE-X19 in Minimal Residual Disease (MRD) Positive B-Cell Acute Lymphoblastic Leukemia (B-ALL)
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 25. ruj 2026. · NCT06144606Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies
U tijeku regrutacijaRana faza 1
Od 18 godina i više · Oba spola · Ažurirano 24. ruj 2026. · NCT06398457Evaluating the Relationship Between Skin Color and Pulse Oximeter Accuracy in Children
U tijeku regrutacijaOpažajna studija
4 Weeks – 18 Years · Oba spola · Ažurirano 24. ruj 2026. · NCT06529575Phase I/II Study of the Combination of Blinatumomab and Asciminib in Patients With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 23. ruj 2026. · NCT06308588Imaging Skeletal Muscle Mitochondrial OXPHOS Activity In Acute Lymphoblastic Leukemia Survivors
U tijeku regrutacijaZdravi dobrovoljci dobrodošli
Od 18 godina i više · Oba spola · Ažurirano 17. ruj 2026. · NCT06819475A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
U tijeku regrutacijaFaza 1/2
30 Days · Oba spola · Ažurirano 16. ruj 2026. · NCT04065399A Study of CD19 Targeted CAR T Cell Therapy in Pediatric Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia (B ALL) and Aggressive Mature B-cell Non-Hodgkin Lymphoma (B NHL)
U tijeku regrutacijaFaza 1
Od 0 do 18 godina · Oba spola · Ažurirano 16. ruj 2026. · NCT06173518Co-Transplant of an Unmodified Haplo-Identical Graft With Cord Blood
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 15. ruj 2026. · NCT06904482Cord Blood Transplant in Adults With Blood Cancers
U tijeku regrutacijaFaza 2
Od 21 do 65 godina · Oba spola · Ažurirano 11. ruj 2026. · NCT05884333Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia
U tijeku regrutacijaFaza 1/2
Od 16 do 75 godina · Oba spola · Ažurirano 10. ruj 2026. · NCT03104491Autologous CD22 CAR T Cells Following Commercial CD19 CAR T Cells in B Cell Malignancies
U tijeku regrutacijaFaza 1
Od 1 do 25 godina · Oba spola · Ažurirano 1. ruj 2026. · NCT06408194First-in-human Study of a New Treatment (4A10) for Patients With Relapsed or Hard-to-treat Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma, Focused on Safety and How the Drug Behaves in the Body and Early Signs of Effect.
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 1. ruj 2026. · NCT07586618Phase I/II Trial: Engineered Donor Graft (Orca Q) for Pediatric Hematopoietic Cell Transplant (HCT)
U tijeku regrutacijaFaza 1/2Zdravi dobrovoljci dobrodošli
Do 50 godina · Oba spola · Ažurirano 1. ruj 2026. · NCT05322850Study of CD19 Allogeneic Memory T-cell Therapy for Relapsed/Refractory CD19+ Leukemia
U tijeku regrutacijaFaza 1
Do 21 godina · Oba spola · Ažurirano 31. kol 2026. · NCT04881240CD45RA-depleted CD19-CAR T Cell Consolidation After TCRαβ+/CD19 B Cell-depleted Haploidentical Hematopoietic Cell Transplantation for Relapsed/Refractory CD19+ ALL and Lymphoma
U tijeku regrutacijaFaza 1
Do 21 godina · Oba spola · Ažurirano 28. kol 2026. · NCT07257419Iz ClinicalTrials.gov, podaci preuzeti 4. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.